Association of the -514C→T polymorphism in the Hepatic Lipase Gene (LIPC) Promoter with Elevated Fasting Insulin Concentrations, but not Insulin Resistance, in Non-diabetic Germans

Abstract

Hepatic lipase hydrolyses triglycerides and phospholipids in all major classes of lipoproteins. The -514C→T genetic variation in the hepatic lipase gene promoter was found to be associated with diminished lipase activity, dyslipidemia, and atherosclerosis. We investigated whether this polymorphism associates with hyperinsulinemia and insulin resistance in 535 normal glucose-tolerant Germans. Only in homozygous individuals (22 subjects), the T allele (frequency: 18.1 %) was significantly associated with elevated glucose concentrations after 120 min of oral glucose tolerance test (p = 0.05) and with elevated fasting concentrations of insulin (p = 0.03), triglycerides (p < 0.01), total and HDL-cholesterol (p = 0.02), as determined by multivariate linear regression analysis. In a recessive model (C/C+C/T vs. T/T), T/T was associated with decreased insulin sensitivity index (p = 0.03) as calculated from oral glucose tolerance test data (n = 535), but not with the glucose infusion rate during hyperinsulinemic euglycemic clamp (n = 218). In conclusion, we have provided evidence that, among the metabolic parameters tested, the hepatic lipase -514C→T gene polymorphism correlates with elevated fasting insulin concentrations in a German population. Since no corresponding difference in insulin sensitivity was seen in the clamp-subgroup, an effect of this polymorphism on insulin clearance has to be considered.

Dyslipidemia - Triglycerides - HDL - Leptin - Insulin sensitivity

References

• 1 Zimmet P, Alberti K GMM, Shaw J. Global and societal implications of the diabetes epidemic.  Nature. 2001;  414 782-787
• 2 Bensadoun A, Berryman D E. Genetics and molecular biology of hepatic lipase.  Curr Opin Lipidol. 1996;  7 77-81
• 3 Santamarina-Fojo S, Haudenschild C, Amar M. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis.  Curr Opin Lipidol. 1998;  9 211-219
• 4 Hegele R, Little J, Vezina C, Maguire G, Tu L, Wolever T, Jenkins D, Connelly P. Hepatic lipase deficiency: clinical, biochemical, and molecular genetic characteristics.  Arterioscler Thromb. 1993;  13 720-728
• 5 Blades B, Vega G L, Grundy S M. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol.  Arterioscler Thromb. 1993;  13 1227-1235
• 6 Zambon A, Austin M A, Brown B G, Hokanson J E, Brunzell J D. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease.  Arterioscler Thromb. 1993;  13 147-153
• 7 Knudsen P, Antikainen M, Ehnholm S, Uusi-Oukari M, Tenkanen H, Lahdenperä S, Kahri J, Tilly-Kiesi M, Bensadoun A, Taskinen M R, Ehnholm C. A compound heterozygote for hepatic lipase gene mutations Leu334→Phe and Thr383→Met: correlation between hepatic lipase activity and phenotypic expression.  J Lipid Res. 1996;  37 825-834
• 8 Dugi K A, Brandauer K, Schmidt N, Nau B, Schneider J G, Mentz S, Keiper T, Schaefer J R, Meissner C, Kather H, Bahner M L, Fiehn W, Kreuzer J. Low hepatic lipase activity is a novel risk factor for coronary artery disease.  Circulation. 2001;  104 3057-3062
• 9 Guerra R, Wang J, Grundy S M, Cohen J C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol.  Proc Natl Acad Sci USA. 1997;  94 4532-4537
• 10 Couture P, Otvos J D, Cupples L A, Lahoz C, Wilson P WF, Schaefer E J, Ordovas J M. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles. The Framingham Offspring Study.  Arterioscler Thromb Vasc Biol. 2000;  20 815-822
• 11 Faggin E, Zambon A, Puato M, Deeb S S, Bertocco S, Sartore S, Crepaldi G, Pessina A C, Pauletto P. Association between the -514C→T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis.  J Am Coll Cardiol. 2002;  40 1059-1066
• 12 Ji J, Herbison C E, Mamotte C D, Burke V, Taylor R R, van Bockxmeer F M. Hepatic lipase gene -514C/T polymorphism and premature coronary heart disease.  J Cardiovasc Risk. 2002;  9 105-113
• 13 Vega G L, Clark L T, Tang A, Marcovina S, Grundy S M, Cohen J C. Hepatic lipase activity is lower in African American men than in white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC).  J Lipid Res. 1998;  39 228-232
• 14 Tahvanainen E, Syvänne M, Frick M H, Murtomäki-Repo S, Antikainen M, Kesäniemi Y A, Kauma H, Pasternak A, Taskinen M R, Ehnholm C. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene.  J Clin Invest. 1998;  101 956-960
• 15 Deeb S S, Peng R. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity.  J Lipid Res. 2000;  41 155-158
• 16 World Health Organization Expert Committee. Second report on diabetes mellitus. Technical report series No. 646, No. 641, Geneva 1980. 
• 17 Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Häring H, Stumvoll M. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.  Diabetes. 2003;  52 239-243
• 18 Matsuda M, DeFronzo R A. Insulin sensitivity indices obtained from oral glucose tolerance testing.  Diabetes Care. 1999;  22 1462-1470
• 19 Hamilton B S, Paglia D, Kwan A YM, Dietel M. Increased obese mRNA expression in omental fat cells from massively obese humans.  Nat Med. 1995;  1 953-956
• 20 Couillard C, Mauriege P, Imbeault P, Prud’homme D, Nadeau A, Tremblay A, Bouchard C, Despres J P. Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia.  Int J Obes Relat Disord. 2000;  24 782-788